Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus

Journal of Chemotherapy

Volumn 24, Issue 4, 2012, Pages 187-190

  Tascini, Carlo ^a   Flammini, Sarah ^a   Leonildi, Alessandro ^a   Ciullo, Ilaria ^a   Tagliaferri, Enrico ^a   Menichetti, Francesco ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Methicillin resistant staphylococcus aureus; Teicoplanin; Vancomycin

Indexed keywords

TEICOPLANIN; VANCOMYCIN;

AGAR DILUTION; ARTICLE; BACTERIUM ISOLATE; BIOASSAY; BROTH DILUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DISK DIFFUSION; DRUG ACTIVITY; EPSILOMETER TEST; IN VITRO STUDY; ITALY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ITALY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84866259922     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947812Y.0000000026     Document Type: Article

References (18)

1. Finch RG, Eliopoulos GM. Safety and efficacy of glycopeptide antibiotics. J Antimicrob Chemother. 2005;55(Suppl. S2):15-13.
2. Beauregard DA, Williams DH, Gwynn MN, Knowles DJ. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob Agents Chemother. 1995;39:781-5.
3. Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother. 1996;37:209-22.
4. Bayer AS. Infective endocarditis. Clin Infect Dis. 1993;17:313-20.
5. Moise PA, Schentag JJ. Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections. Int J Antimicrob Agents. 2001;16:31-4.
6. Wang G, Hindler JF, Ward KW, Bruckner DA. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol. 2006;44:3883-6.
7. Campanile F, Bongiorno D, Borbone S, Stefani S. Hospital associated methicillin-resistant Staphylococcus aureus (HAMRSA) in Italy. Ann Clin Microbiol Antimicrob. 2009;8:22.
8. Musta AC, Riederer K, Shemes S, Chase P, Jose J, Johnson LB, et al. Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years. J Clin Microbiol. 2009;47:1640-4.
9. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.1. Basel, EUCAST; 2010.
10. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. Volume 28, No. 1. Wayne, PA: CLSI; 2008.
11. Pantosti A, Sanchini A, Monaco M. Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol. 2007;2:323-34.
12. Jones RN. Key considerations in the treatment of complicated staphylococcal infections. Clin Microbiol Infect. 2008;14(Suppl 2):3-9.
13. Henwood CJ, Livermore DM, Johnson AP, James D, Warner M, Gardiner A. Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. TheLinezolid Study Group. J Antimicrob Chemother. 2000;46:931-40.
14. Cassone M, Campanile F, Pantosti A, Venditti M, Stefani S. Identification of a variant 'Rome clone' of methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin, responsible for an outbreak in an intensive care unit. Microb Drug Resist. 2004;10:43-9.
15. Marchese A, Balistreri G, Tonoli E, Debbia EA, Schito GC. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol. 2000;38:866-9.
16. Monaco M, Sanchini A, Grundmann H, Pantosti A, The EARSS-Italy S. aureus Typing Group. Vancomycin-heteroresistant phenotype in invasive methicillin-resistant Staphylococcus aureus isolates belonging to spa type 041. Eur J Clin Microbiol Infect Dis. 2010;29:771-7.
17. Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptideintermediate isolates of Staphylococcus aureus. Antimicrob Agents Chemother. 2010;54:3861-70.
18. Hsu DI, Hidayat LK, Quist R, Hindler J, Karlsson A, Yusof A, et al. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents. 2008;32:378-85.